Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study.
Xia D, Bai W, Wang Q, Chung JW, Adhoute X, Kloeckner R, Zhang H, Zeng Y, Sripongpun P, Nie C, Kim SU, Huang M, Hu W, Ding X, Yin G, Li H, Zhao H, Bronowicki JP, Li J, Li J, Zhu X, Wu J, Zhang C, Gong W, Li Z, Lin Z, Xu T, Yin T, Anty R, Song J, Shi H, Shao G, Ren W, Zhang Y, Yang S, Zheng Y, Xu J, Wang W, Zhu X, Fu Y, Liu C, Kaewdech A, Ding R, Zheng J, Liu S, Yu H, Zheng L, You N, Fan W, Zhang S, Feng L, Wang G, Zhang P, Li X, Chen J, Zhang F, Shao W, Zhou W, Zeng H, Cao G, Huang W, Jiang W, Zhang W, Li L, Feng A, Wang E, Wang Z, Han D, Lv Y, Sun J, Ren B, Xia L, Li X, Yuan J, Wang Z, Luo B, Li K, Guo W, Yin Z, Zhao Y, Xia J, Fan D, Wu K, Bettinger D, Vogel A, Han G; China HCC-TACE study group. Xia D, et al. Among authors: adhoute x. JHEP Rep. 2024 Sep 12;7(1):101216. doi: 10.1016/j.jhepr.2024.101216. eCollection 2025 Jan. JHEP Rep. 2024. PMID: 39758510 Free PMC article.
COSMIC-312, a disappointing result-is that so surprising?
Adhoute X, Bourlière M, Anty R. Adhoute X, et al. Ann Transl Med. 2024 Aug 1;12(4):59. doi: 10.21037/atm-23-421. Epub 2023 Mar 2. Ann Transl Med. 2024. PMID: 39118945 Free PMC article. No abstract available.
Outcomes and safety of atezolizumab plus bevacizumab in the treatment of hepatocellular carcinoma: treatment prognosis and comparison with tyrosine kinase inhibitors in a French multicenter matched real-life study.
Adhoute X, Gonzalez A, Levi-Strauss T, Mineur L, Pénaranda G, Sellier F, Toullec C, Pietri O, Castellani P, Tran A, Perrier H, Bourliere M, Anty R. Adhoute X, et al. Eur J Gastroenterol Hepatol. 2024 Nov 1;36(11):1329-1339. doi: 10.1097/MEG.0000000000002830. Epub 2024 Jul 26. Eur J Gastroenterol Hepatol. 2024. PMID: 39083056
Surgical treatment of tertiary hyperparathyroidism: does one fit for all?
Casella C, Guarneri C, Campanile M, Adhoute X, Gelera PP, Morandi R. Casella C, et al. Among authors: adhoute x. Front Endocrinol (Lausanne). 2023 Nov 2;14:1226917. doi: 10.3389/fendo.2023.1226917. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38027172 Free PMC article.
Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma: Real-life Data on Liver Disease, Treatment and Prognosis.
Adhoute X, Pietri O, Pénaranda G, Wolf T, Beaurain P, Monnet O, Laquière A, Bonomini J, Neumann F, Levrel O, Buono JP, Hanna X, Castellani P, Perrier H, Bourliere M, Anty R. Adhoute X, et al. J Clin Transl Hepatol. 2023 Oct 28;11(5):1106-1117. doi: 10.14218/JCTH.2022.00141. Epub 2023 May 16. J Clin Transl Hepatol. 2023. PMID: 37577232 Free PMC article.
Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study.
Gronnier C, Mariette C, Lepage C, Monterymard C, Jary M, Ferru A, Baconnier M, Adhoute X, Tavan D, Perrier H, Guerin-Meyer V, Lecaille C, Bonichon-Lamichhane N, Pillon D, Cojocarasu O, Egreteau J, D'journo XB, Dahan L, Locher C, Texereau P, Collet D, Michel P, Ben Abdelghani M, Guimbaud R, Muller M, Bouché O, Piessen G. Gronnier C, et al. Among authors: adhoute x. Cancers (Basel). 2023 Apr 6;15(7):2188. doi: 10.3390/cancers15072188. Cancers (Basel). 2023. PMID: 37046849 Free PMC article.
Radiomics, a Promising New Discipline: Example of Hepatocellular Carcinoma.
Lévi-Strauss T, Tortorici B, Lopez O, Viau P, Ouizeman DJ, Schall B, Adhoute X, Humbert O, Chevallier P, Gual P, Fillatre L, Anty R. Lévi-Strauss T, et al. Among authors: adhoute x. Diagnostics (Basel). 2023 Mar 30;13(7):1303. doi: 10.3390/diagnostics13071303. Diagnostics (Basel). 2023. PMID: 37046521 Free PMC article. Review.
Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching.
Adhoute X, De Matharel M, Mineur L, Pénaranda G, Ouizeman D, Toullec C, Tran A, Castellani P, Rollet A, Oules V, Perrier H, Si Ahmed SN, Bourliere M, Anty R. Adhoute X, et al. World J Gastrointest Oncol. 2022 Aug 15;14(8):1510-1527. doi: 10.4251/wjgo.v14.i8.1510. World J Gastrointest Oncol. 2022. PMID: 36160737 Free PMC article.
63 results